Metropolitan Life Insurance Company (MetLife)’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,395
Closed -$15.7K 1903
2024
Q1
$15.7K Hold
2,395
﹤0.01% 1964
2023
Q4
$15.5K Hold
2,395
﹤0.01% 2025
2023
Q3
$12K Hold
2,395
﹤0.01% 2134
2023
Q2
$21K Buy
+2,395
New +$21K ﹤0.01% 1904